increased susceptibility to pharmacologically induced seizures_Drd2<tm1Ebo>/Drd2<tm1Ebo>

http://metadb.riken.jp/0002906I129S2SvPasC57BL6Drd2tm1EboDrd2tm1EboDrd2tm1Ebo

increased susceptibility to pharmacologically induced seizures_Drd2<tm1Ebo>/Drd2<tm1Ebo>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• dopamine receptor D2
  http://metadb.riken.jp/db/mgi_rdf/MGI:94924

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Drd2<tm1Ebo>/Drd2<tm1Ebo>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Drd2<tm1Ebo>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S2/SvPas * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased susceptibility to pharmacologically induced seizures
  http://purl.obolibrary.org/obo/MP_0002906

文献

http://purl.org/net/cito/citesAsAuthority

• Y. Bozzi, et.al., Neuroprotective role of dopamine against hippocampal cell death., The Journal of neuroscience : the official journal of the Society for Neuroscience, 2000, 20
  http://rdf.ncbi.nlm.nih.gov/pubmed/11069974